Rosiglitazone
Rosiglitazone is a pharmaceutical drug with 122 clinical trials. Currently 1 active trials ongoing. Historical success rate of 87.0%.
Success Metrics
Based on 94 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
22
Mid Stage
64
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.9%
94 of 112 finished
16.1%
18 ended early
1
trials recruiting
122
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
Clinical Trials (122)
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
Rosiglitazone Adjunctive Therapy for Severe Malaria in Children
BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Role of Insulin Action and Free Fatty Acids in Hyperandrogenism of Women With Polycystic Ovary Syndrome
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
BAY73-4506 Probe Substrate Study
Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study
Effect of Rosiglitazone
Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM
Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health
Preferred Treatment of Type 1.5 Diabetes
A Trial of Rosiglitazone for Ulcerative Colitis
11ß-HSD1 and Metabolic Syndrome
Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide
Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas
Efficacy and Safety In Poorly Controlled Type 2 Diabetics
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 122